Welcome to "Fly Insider," The Fly's weekly recap of notable insider stock transactions.

NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from December 16 through December 20 include:

• Chairman of Neoleukin Therapeutics (NLTX) Jonathan Drachman purchased 119,047 shares of company stock at $8.40 per share for a total transaction value of $999,995

• Chairman of Enterprise Products Partners (EPD) Randa Duncan Williams purchased 83,000 shares of company stock at $27.91 per share for a total transaction value of $2,316,123

• Director of Franchise Group (FRG) Matthew Avril purchased 75,469 shares of company stock at $13.25 per share for a total transaction value of $1,000,010

• CEO of RiceBran Technologies (RIBT) Brent Rystrom purchased 80,000 shares of company stock at $1.25 per share for a total transaction value of $100,000; Director David Chemerow purchased 80,000 shares of company stock at $1.25 per share for a total transaction value of $100,000

• CEO of Children's Place (PLCE) Jane Elfers purchased 18,100 shares of company stock at $55.54 per share for a total transaction value of $1,005,274

NOTABLE INSIDER SALES: Significant insider sales reported in the prior week from December 16 through December 20 include:

• Founder of Uber Technologies (UBER) Travis Kalanick sold 12,790,960 shares of company stock at $29.96 per share for a total transaction value of $383,215,883

• Director of Brigham Minerals (MNRL) Howard Keenan sold 1,847,225 shares of company stock at $17.38 per share for a total transaction value of $32,097,382

• Director of Phreesia (PHR) Edward Cahill sold 2,181,577 shares of company stock at $24.48 per share for a total transaction value of $53,402,823

• Chairman of Continental Resources (CLR) Harold Hamm sold 1,779,496 shares of company stock at $33.87 per share for a total transaction value of $60,278,114

• Chairman of Salesforce (CRM) Marc Benioff sold 53,910 shares of company stock at $162.64 per share for a total transaction value of $8,767,658

NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTIONS: Shares of Neoleukin Therapeutics are up 30% after cChairman Jonathan Drachman bought shares, while shares of Phreesia are down by approximately 6% after director Edward Cahill sold shares.